Eli & Co Lilly, 10% Owner at Zymeworks Inc. (ZYME), sold 31,748 shares at $14.58 ($463K) on 2018-09-14, disclosed to the SEC on 2018-09-18.
Open-market sale of $463k ZYME by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.58 | 9,009 | $131K | 28.4% |
| 2 | $14.58 | 9,009 | $131K | 28.4% |
| 3 | $14.58 | 6,865 | $100K | 21.6% |
| 4 | $14.58 | 6,865 | $100K | 21.6% |
| Total | $14.58 avg | 31,748 | $463K | 100% |
| Filing → |
| ZYME | SELL | 2018-09-26 | $33K | — | Filing → |
| ZYME | SELL | 2018-09-20 | $200K | — | Filing → |
| ZYME | SELL | 2018-09-14 | $598K | — | Filing → |